University of Maryland School of Medicine: New Innovation in CAR T-Cells Paves Way for Less Toxic Therapy Against Multiple Myeloma
July 20, 2023
July 20, 2023
BALTIMORE, Maryland, July 20 (TNSjou) -- The University of Maryland School of Medicine issued the following news on July 19, 2023:
University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the likelihood of toxic side effects from this innovative cancer treatment. The cells were designed specifically to attack multiple myel . . .
University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the likelihood of toxic side effects from this innovative cancer treatment. The cells were designed specifically to attack multiple myel . . .